Faculty profile

Renee Korol

Back to faculty

Assistant ProfessorDepartment of Radiation OncologyUniversity of Toronto

Renee Korol

Assistant Professor

Department of Radiation Oncology

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
4 publications in the last five years, latest in 2025.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

723

Citations

Collaborators

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Every Other Day or Once a Week: Long-term Oncological Outcomes in the Phase 2 PATRIOT Trial of Prostate Stereotactic Ablative Body Radiotherapy.
European urology oncology · 2025
Stereotactic Radiation Therapy for Localized Prostate Cancer: 10-Year Outcomes From Three Prospective Trials.
International journal of radiation oncology, biology, physics · 2025
Predictors of pathologic fracture and local recurrence following stereotactic body radiation therapy to 505 non-spine bone metastases.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2023

All 15 publications

15 publications.

Every Other Day or Once a Week: Long-term Oncological Outcomes in the Phase 2 PATRIOT Trial of Prostate Stereotactic Ablative Body Radiotherapy.

Ong WL, Quon H, Ong A, Cheung P, Chu W, Chung H, Vesprini D, Chowdhury A, Panjwani D, Alayed Y, Pang G, Korol R, Davidson M, Ravi A, McCurdy B, Zhang L, Kulasingham-Poon M, Mamedov A, Deabreu A, Loblaw A

European urology oncology20253 citationsOpen Access

DOI: 10.1016/j.euo.2025.03.011 PMID: 40288917

Stereotactic Radiation Therapy for Localized Prostate Cancer: 10-Year Outcomes From Three Prospective Trials.

Kennedy TAC, Ong WL, Quon H, Cheung P, Chu W, Chung H, Vesprini D, Panjwani D, Alayed Y, Pang G, Korol R, Zhang L, Mamedov A, Deabreu A, Loblaw A

International journal of radiation oncology, biology, physics2025

DOI: 10.1016/j.ijrobp.2024.09.009 PMID: 39293531

Predictors of pathologic fracture and local recurrence following stereotactic body radiation therapy to 505 non-spine bone metastases.

Nguyen EK, Korol R, Ali S, Cumal A, Erler D, Louie AV, Nguyen TK, Poon I, Cheung P, Chu W, Soliman H, Vesprini D, Sahgal A, Chen H

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology202311 citations

DOI: 10.1016/j.radonc.2023.109792 PMID: 37414253

Toxicity and Efficacy of Multitarget Thoracic Stereotactic Body Radiation Therapy

Eric K. Nguyen, Ian Poon, Yee Ung, May N. Tsao, Renee M. Korol, Alyaa H. Elzibak, Darby Erler, Liying Zhang, Alexander V. Louie, Patrick Cheung

International Journal of Radiation Oncology*Biology*Physics20222 citations

DOI: 10.1016/j.ijrobp.2022.10.032 PMID: 36368432

Accelerating prostate stereotactic ablative body radiotherapy: Efficacy and toxicity of a randomized phase II study of 11 versus 29 days overall treatment time (PATRIOT).

Alayed Y, Quon H, Ong A, Cheung P, Chu W, Chung H, Vesprini D, Chowdhury A, Panjwani D, Pang G, Korol R, Davidson M, Ravi A, McCurdy B, Zhang L, Mamedov A, Deabreu A, Loblaw A

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology202045 citations

DOI: 10.1016/j.radonc.2020.04.039 PMID: 32416376

Evaluating the Tolerability of a Simultaneous Focal Boost to the Gross Tumor in Prostate SABR: A Toxicity and Quality-of-Life Comparison of Two Prospective Trials.

Alayed Y, Davidson M, Liu S, Chu W, Tseng E, Cheung P, Vesprini D, Cheung H, Morton G, Musunuru HB, Ravi A, Korol R, Deabreu A, Ho L, Commisso K, Bhounr Z, D'Alimonte L, Mittmann N, Dragomir A, Zhang L, Loblaw A

International journal of radiation oncology, biology, physics202035 citations

DOI: 10.1016/j.ijrobp.2019.12.044 PMID: 31987962

Dosimetric predictors of toxicity and quality of life following prostate stereotactic ablative radiotherapy.

Alayed Y, Davidson M, Quon H, Cheung P, Chu W, Chung HT, Vesprini D, Ong A, Chowdhury A, Liu SK, Panjwani D, Helou J, Musunuru HB, Pang G, Korol R, Ravi A, McCurdy B, Zhang L, Mamedov A, Deabreu A, Commisso A, Commisso K, D'Alimonte L, Ho L, Bhounr Z, Loblaw A

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology202026 citations

DOI: 10.1016/j.radonc.2019.11.017 PMID: 31809979

Two versus five stereotactic ablative radiotherapy treatments for localized prostate cancer: A quality of life analysis of two prospective clinical trials.

Alayed Y, Quon H, Cheung P, Chu W, Chung HT, Vesprini D, Ong A, Chowdhury A, Panjwani D, Helou J, Pang G, Korol R, Davidson M, Ravi A, McCurdy B, Zhang L, Mamedov A, Deabreu A, Commisso A, Commisso K, Loblaw A

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology201918 citations

DOI: 10.1016/j.radonc.2019.06.018 PMID: 31265940

Quality of life changes after stereotactic ablative radiotherapy for liver metastases: A prospective cohort analysis.

Helou J, Thibault I, Chu W, Munoz-Schuffenegger P, Erler D, Rodrigues G, Warner A, Chan KKW, Chow E, Korol R, Davidson M, Chung HT

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology201810 citations

DOI: 10.1016/j.radonc.2018.09.011 PMID: 30274721

Positional Accuracy of Treating Multiple Versus Single Vertebral Metastases With Stereotactic Body Radiotherapy.

Chang JH, Sangha A, Hyde D, Soliman H, Myrehaug S, Ruschin M, Lee Y, Sahgal A, Korol R

Technology in cancer research & treatment201716 citationsSenior authorOpen Access

DOI: 10.1177/1533034616681674 PMID: 28279146

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Renee Korol

Research

Latest papers

Every Other Day or Once a Week: Long-term Oncological Outcomes in the Phase 2 PATRIOT Trial of Prostate Stereotactic Ablative Body Radiotherapy.

Stereotactic Radiation Therapy for Localized Prostate Cancer: 10-Year Outcomes From Three Prospective Trials.

Predictors of pathologic fracture and local recurrence following stereotactic body radiation therapy to 505 non-spine bone metastases.

Toxicity and Efficacy of Multitarget Thoracic Stereotactic Body Radiation Therapy

Accelerating prostate stereotactic ablative body radiotherapy: Efficacy and toxicity of a randomized phase II study of 11 versus 29&#xa0;days overall treatment time (PATRIOT).

Evaluating the Tolerability of a Simultaneous Focal Boost to the Gross Tumor in Prostate SABR: A Toxicity and Quality-of-Life Comparison of Two Prospective Trials.

Dosimetric predictors of toxicity and quality of life following prostate stereotactic ablative radiotherapy.

Two versus five stereotactic ablative radiotherapy treatments for localized prostate cancer: A quality of life analysis of two prospective clinical trials.

Quality of life changes after stereotactic ablative radiotherapy for liver metastases: A prospective cohort analysis.

Positional Accuracy of Treating Multiple Versus Single Vertebral Metastases With Stereotactic Body Radiotherapy.

Frequent collaborators

William Chu

Patrick Cheung

Danny Vesprini

Andrew Loblaw

Arjun Sahgal

Geordi Pang

Boyd McCurdy

Hans Chung

Darby Erler

Hany Soliman

Ian Poon

Eric Nguyen

Stanley Liu

Edward Chow

May Tsao

Peter Howard

Eugene Yu

Sten Myrehaug

Michael Lock

Mark Ruschin

Alice Dragomir

Isabelle Thibault

Eric Tseng

Hanbo Chen

Nicole Mittmann

Andrew Chiang

Michael Fehlings

Kelvin Chan

Accelerating prostate stereotactic ablative body radiotherapy: Efficacy and toxicity of a randomized phase II study of 11 versus 29 days overall treatment time (PATRIOT).